Synapmed
Overview
Synapmed is a medical technology company focused on developing and commercializing innovative solutions for neurological disorders. They specialize in leveraging advanced imaging techniques, artificial intelligence, and data analytics to improve the diagnosis, treatment, and management of conditions such as Alzheimer's disease, Parkinson's disease, and stroke.
About Us
Synapmed (formerly AstaLynx Global) is a Contract Research Organization (CRO) providing Real World Data and AI enabled solutions and services across the Target to Market spectrum.
Vision
To be a global leader in neurological medical technology, transforming the standard of care for patients with neurological disorders through innovative solutions and collaborative partnerships.
Mission
To develop and deliver innovative medical technologies that improve the diagnosis, treatment, and management of neurological disorders, ultimately enhancing the quality of life for patients and their families.
Culture
Synapmed fosters a culture of innovation, collaboration, and patient-centricity. The company values creativity, scientific rigor, and a commitment to excellence. They encourage employees to challenge conventional thinking and pursue novel approaches to address complex neurological challenges. Synapmed prioritizes teamwork and open communication, creating an environment where diverse perspectives are valued and employees are empowered to make a meaningful impact.
Headquarters
New York